David Ilfeld

604 total citations
37 papers, 452 citations indexed

About

David Ilfeld is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, David Ilfeld has authored 37 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in David Ilfeld's work include Immune Cell Function and Interaction (11 papers), Asthma and respiratory diseases (8 papers) and Inflammasome and immune disorders (7 papers). David Ilfeld is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Asthma and respiratory diseases (8 papers) and Inflammasome and immune disorders (7 papers). David Ilfeld collaborates with scholars based in Israel, United States and Sweden. David Ilfeld's co-authors include O Kuperman, Claude Carnaud, Nathan Trainin, Randall S. Krakauer, Moshe Garty, R. Michael Blaese, Irun R. Cohen, M Schlesinger, M Topilsky and Joseph B. Rosenfeld and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and The American Journal of Medicine.

In The Last Decade

David Ilfeld

37 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ilfeld Israel 14 203 100 86 70 45 37 452
Jakob Björk Sweden 11 147 0.7× 85 0.8× 64 0.7× 42 0.6× 26 0.6× 14 423
Jeffress G. Palmer United States 12 133 0.7× 68 0.7× 52 0.6× 35 0.5× 20 0.4× 22 478
Tung‐Nan Liao Taiwan 14 149 0.7× 174 1.7× 154 1.8× 85 1.2× 27 0.6× 20 601
Hy Goldman Canada 18 105 0.5× 139 1.4× 79 0.9× 31 0.4× 41 0.9× 37 806
Howard S. Freeland United States 9 122 0.6× 46 0.5× 168 2.0× 89 1.3× 32 0.7× 13 379
Shigenori Nakajima Japan 13 79 0.4× 85 0.8× 193 2.2× 135 1.9× 45 1.0× 52 448
Willis R. Keene United States 10 79 0.4× 56 0.6× 57 0.7× 35 0.5× 11 0.2× 12 418
M Spielberger Austria 9 114 0.6× 94 0.9× 28 0.3× 29 0.4× 35 0.8× 32 489
Kuznik Bi Russia 11 66 0.3× 79 0.8× 132 1.5× 25 0.4× 40 0.9× 125 405
M C Gutowski France 8 148 0.7× 42 0.4× 106 1.2× 18 0.3× 88 2.0× 12 490

Countries citing papers authored by David Ilfeld

Since Specialization
Citations

This map shows the geographic impact of David Ilfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ilfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ilfeld more than expected).

Fields of papers citing papers by David Ilfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ilfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ilfeld. The network helps show where David Ilfeld may publish in the future.

Co-authorship network of co-authors of David Ilfeld

This figure shows the co-authorship network connecting the top 25 collaborators of David Ilfeld. A scholar is included among the top collaborators of David Ilfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ilfeld. David Ilfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kivity, Shmuel, David Ilfeld, M Schlesinger, et al.. (1990). A clinical and immunologic study of colchicine in asthma. Journal of Allergy and Clinical Immunology. 85(3). 578–582. 27 indexed citations
2.
Garty, Moshe, et al.. (1989). Increased theophylline clearance in asthmatic patients due to terbutaline. European Journal of Clinical Pharmacology. 36(1). 25–28. 5 indexed citations
3.
Garty, Moshe, et al.. (1986). Effect of nifedipine and theophylline in asthma. Clinical Pharmacology & Therapeutics. 40(2). 195–198. 16 indexed citations
4.
Ilfeld, David, et al.. (1986). Correlation of Fcγ receptors on peripheral blood mononuclear cells and survival in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 7(3). 181–186. 4 indexed citations
5.
Garty, Moshe, Guy M. L. Perry, David Ilfeld, et al.. (1986). Effect of cimetidine on digoxin disposition in peptic ulcer patients. European Journal of Clinical Pharmacology. 30(4). 489–491. 7 indexed citations
6.
Danziger, Y, et al.. (1985). Reduction of serum theophylline levels by terbutaline in children with asthma. Clinical Pharmacology & Therapeutics. 37(4). 469–471. 17 indexed citations
7.
Garty, Moshe, David Ilfeld, & John G. Kelton. (1985). Correlation of a quinidine-induced platelet-specific antibody with development of thrombocytopenia. The American Journal of Medicine. 79(2). 253–255. 9 indexed citations
8.
Ilfeld, David, O Kuperman, Shmuel Kivity, et al.. (1984). Effect of colchicine on T cell subsets of healthy volunteers.. PubMed. 53(3). 595–8. 6 indexed citations
9.
Kuperman, O, et al.. (1982). Nonspecific Suppressor Cell Activity and Lymphocyte Response to β-Lactoglobulin in Cowʼs Milk Protein Hypersensitivity. Journal of Pediatric Gastroenterology and Nutrition. 1(3). 389–394. 11 indexed citations
10.
Ilfeld, David, et al.. (1981). Suppressor cell function in a family with familial Mediterranean fever.. PubMed. 43(2). 357–61. 8 indexed citations
11.
Ilfeld, David, et al.. (1981). Immunoregulatory abnormalities in familial Mediterranean fever. Clinical Immunology and Immunopathology. 18(2). 261–267. 14 indexed citations
12.
Ilfeld, David, Martha K. Cathcart, Randall S. Krakauer, & Michael Blaese. (1981). Human splenic and peripheral blood lymphocyte response to lipopolysaccharide. Cellular Immunology. 57(2). 400–407. 9 indexed citations
13.
Ilfeld, David & Randall S. Krakauer. (1980). Suppression of immunoglobulin synthesis of systemic lupus erythematosus patients by concanavalin A-activated normal human spleen cell supernatants. Clinical Immunology and Immunopathology. 17(2). 196–202. 4 indexed citations
14.
Krakauer, Randall S., Martha K. Cathcart, & David Ilfeld. (1980). Suppression of polyclonal immunoglobulin biosynthesis by a soluble factor: T-cell dependent and T-cell independent mitogens.. PubMed. 40(1). 53–60. 5 indexed citations
15.
Krakauer, Randall S., John D. Clough, & David Ilfeld. (1980). Recent advances in autoimmunity. Cleveland Clinic Journal of Medicine. 47(2). 73–78. 2 indexed citations
16.
Steinberg, Alfred D., Randall S. Krakauer, James L. Reinertsen, et al.. (1978). Therapeutic studies in NZB/NZW mice.. Arthritis & Rheumatism. 21(2). 204–209. 19 indexed citations
17.
Ilfeld, David, Claude Carnaud, & Eva Klein. (1975). Cytotoxicity of autosensitized lymphocytes restricted to the H-2K end of targets. Immunogenetics. 2(1). 231–240. 13 indexed citations
18.
Carnaud, Claude, David Ilfeld, Itzhak Brook, & Nathan Trainin. (1973). INCREASED REACTIVITY OF MOUSE SPLEEN CELLS SENSITIZED IN VITRO AGAINST SYNGENEIC TUMOR CELLS IN THE PRESENCE OF A THYMIC HUMORAL FACTOR. The Journal of Experimental Medicine. 138(6). 1521–1532. 23 indexed citations
19.
Trainin, Nathan, Claude Carnaud, & David Ilfeld. (1973). Inhibition of in vitro Autosensitization by a Thymic Humoral Factor. Nature New Biology. 245(147). 253–255. 15 indexed citations
20.
Ilfeld, David, K. A. Wright, & Ferdinand A. Salzman. (1971). SYNCHRONOUS SHIELDING AND FIELD SHAPING FOR MEGAVOLT IRRADIATION OF ADVANCED CERVICAL CARCINOMA. American Journal of Roentgenology. 112(4). 792–796. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakob Björk Breakdown of academic impact, for papers by Jeffress G. Palmer Breakdown of academic impact, for papers by Tung‐Nan Liao Breakdown of academic impact, for papers by Hy Goldman Breakdown of academic impact, for papers by Howard S. Freeland Breakdown of academic impact, for papers by Shigenori Nakajima Breakdown of academic impact, for papers by Willis R. Keene Breakdown of academic impact, for papers by M Spielberger Breakdown of academic impact, for papers by Kuznik Bi Breakdown of academic impact, for papers by M C Gutowski
Rankless by CCL
2026